Is KMS Medisurgi overvalued or undervalued?
As of September 16, 2025, KMS Medisurgi is considered very expensive and overvalued with a PE ratio of 41.75, an EV to EBIT ratio of 41.87, and a Price to Book Value of 5.45, underperforming the Sensex and raising concerns about its growth prospects.
As of 16 September 2025, the valuation grade for KMS Medisurgi has moved from risky to very expensive. The company is currently considered overvalued, with a PE ratio of 41.75, an EV to EBIT ratio of 41.87, and a Price to Book Value of 5.45. These figures suggest that the stock is trading at a premium compared to its earnings and book value.In comparison to its peers, KMS Medisurgi's PE ratio is lower than Poly Medicure's 56.1 but higher than Blue Jet Health's 34.66, indicating a mixed competitive positioning. The PEG ratio stands at 0.00, which raises concerns about growth prospects relative to its valuation. Notably, while KMS Medisurgi has delivered a 1.2% return year-to-date, it has underperformed the Sensex, which has returned 5.43% in the same period, further reinforcing the notion of overvaluation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
